05/05/2022 | Press release | Distributed by Public on 05/05/2022 00:08
05 May 2022 08:00 CEST
ULTIMOVACS
NO0010851603
Oslo Børs
ULTI
Ultimovacs ASA: Invitation to first quarter 2022 results webcast presentation
Oslo, 5 May 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage
leader in immune stimulatory vaccines for cancer, invites to a webcast
presentation of its first quarter 2022 results on Thursday 12 May 2022.
The presentation can be followed as a live webcast accessed through a link on
www.ultimovacs.com at 13:00 CET on Thursday 12 May 2022. The webcast
presentation will be available on the Ultimovacs website, and it will be
possible to post questions during the presentation through the webcast.
The report and presentation will be available on the company website from 08:00
CET the same day.
For further information, please see www.ultimovacs.com or contact:
Carlos de Sousa, CEO
Email: [email protected]
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: [email protected]
Phone: +47 482 48632
Anne Worsøe, Head of IR & Communication
Email: [email protected]
Phone: +47 906 86815
More information:
Access the news on Oslo Bors NewsWeb site
Ultimovacs ASA
Oslo Børs Newspoint